GLP-1 Pill Fails to Slow Alzheimer’s Progression in Clinical Trial

www.scientificamerican.com

GLP-1 Pill Fails to Slow Alzheimer’s Progression in Clinical Trial

www.scientificamerican.com

paywallMB to Scientific AmericanEnglish · 1 day ago

Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral semaglutide failed to slow down Alzheimer's progression

From Scientific American via this RSS feed

You must log in or # to comment.

Chat

Scientific American

scientificamerican

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !scientificamerican@ibbit.at

Community locked: only moderators can create posts. You can still comment on posts.

Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

13 users / day
64 users / week
130 users / month
288 users / 6 months
1 local subscriber
20 subscribers
661 Posts
55 Comments
Modlog